Convergencehealth is categorized under Health Screening Services in Incline Village, NV and active since 1994.
Convergencehealth was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Screening Services business, which does work in the B2C market, and is classified as a Health Screening Services, under code number 5312100 by the NAICS.
If you are seeking more information, feel free to contact Byron Gehring at the company’s single location by writing to 920 Incline Way, Incline Village, Nevada NV 89451 or by phoning (775) 832-6555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Convergencehealth |
| Contact Person: | Byron Gehring |
| Address: | 920 Incline Way, Incline Village, Nevada 89451 |
| Phone Number: | (775) 832-6555 |
| Website Address: | convergencehealth.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Screening Services |
| SIC Code: | 8099 |
| NAICS Code: | 5312100 |
| Share This Business: |
Convergencehealth was started in 1994 to provide professional Health Screening Services under the SIC code 8099 and NAICS code 5312100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Byron Gehring for inquiries that concern Convergencehealth by calling the company number (775) 832-6555, as your correspondence is most welcome. Additionally, the physical location of the single location of Convergencehealth can be found at the coordinates 39.248139,-119.950877 as well as the street address 920 Incline Way in Incline Village, Nevada 89451.
For its online presence, you may visit Convergencehealth’s website at convergencehealth.com and engage with its social media outlets through on Twitter and on Facebook.